DELCATH SYSTEMS, INC. (DCTH)
Data as of , from SEC Form 4 filings.
See up to 3 months of DCTH. The 7-day demo opens the 1M and 3M ranges and puts DCTH on your watchlist.
Start 7-day demoLatest DCTH insider trades
Sandra Pennell - OfficerOpen-market purchase$50K- Gerard J. Michel - OfficerOpen-market purchase$100K
About DELCATH SYSTEMS, INC. (DCTH)
DELCATH SYSTEMS, INC. files with the SEC under CIK 0000872912 and is classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
DCTH Form 4 activity by transaction type, last 90 days
No Form 4 activity for DCTH in the last 90 days.
DCTH insider transactions (Form 4)
3623 Form 4 filings on record, the earliest from Oct 23, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Richard Sylvester | Grant or award | Stock Option (right to buy) | 22,500 | $0.00 | - | |
 Bridget A. Martell | Grant or award | Stock Option (right to buy) | 22,500 | $0.00 | - | |
| Elizabeth Czerepak | Grant or award | Stock Option (right to buy) | 22,500 | $0.00 | - | |
| Steven A. J. Salamon | Grant or award | Stock Option (right to buy) | 22,500 | $0.00 | - | |
| Gil Aharon | Grant or award | Stock Option (right to buy) | 22,500 | $0.00 | - | |
| Sandra Pennell - Officer | Open-market purchase | Common Stock | 5,533 | $9.04 | $50K | |
| Gerard J. Michel - Officer | Open-market purchase | Common Stock | 11,200 | $8.96 | $100K | |
| David L. Hoffman - Officer | Grant or award | Stock Option (Right to Buy) | 56,500 | $0.00 | - | |
| David L. Hoffman - Officer | Grant or award | Restricted Stock Units | 28,250 | $0.00 | - | |
| Kevin Muir - Officer | Grant or award | Stock Option (Right to Buy) | 56,500 | $0.00 | - | |
| Kevin Muir - Officer | Grant or award | Restricted Stock Units | 28,250 | $0.00 | - | |
| Sandra Pennell - Officer | Grant or award | Stock Option (Right to Buy) | 56,500 | $0.00 | - | |
| Sandra Pennell - Officer | Grant or award | Restricted Stock Units | 28,250 | $0.00 | - | |
| Vojo Vukovic - Officer | Grant or award | Stock Option (Right to Buy) | 56,500 | $0.00 | - | |
| Vojo Vukovic - Officer | Grant or award | Restricted Stock Units | 28,250 | $0.00 | - | |
 Martha S. Rook - Officer | Grant or award | Stock Option (Right to Buy) | 56,500 | $0.00 | - | |
| Martha S. Rook - Officer | Grant or award | Restricted Stock Units | 28,250 | $0.00 | - | |
| Gerard J. Michel - Officer | Grant or award | Stock Option (Right to Buy) | 195,000 | $0.00 | - | |
| Gerard J. Michel - Officer | Grant or award | Restricted Stock Units | 97,500 | $0.00 | - | |
| John Richard Sylvester | Open-market purchase | Common Stock | 4,386 | $8.89 | $39K | |
| Gerard J. Michel - Officer | Open-market purchase | Common Stock | 11,500 | $8.53 | $98K | |
| Elizabeth Czerepak | Grant or award | Stock Option (right to buy) | 22,500 | $0.00 | - | |
| Steven A. J. Salamon - Director | Other | Common shares | 250,000 | $10.00 | $2.50M | |
| Steven A. J. Salamon - Director | Option exercise | Pre-funded Warrants | 603,954 | $9.99 | $6.03M | |
| Gil Aharon - Director | Other | Common shares | 250,000 | $10.00 | $2.50M | |
| Gil Aharon - Director | Option exercise | Pre-funded Warrants | 603,954 | $9.99 | $6.03M | |
| Rosalind Advisors, Inc. - Director | Other | Common shares | 250,000 | $10.00 | $2.50M | |
| Rosalind Advisors, Inc. - Director | Option exercise | Pre-funded Warrants | 603,954 | $9.99 | $6.03M | |
| Gil Aharon - Director | Option exercise | Tranche B warrants to purchase F-4 Preferred Stock | 500 | $1,000.00 | $500K | |
| Gil Aharon - Director | Other | 8% CONVERTIBLE NOTE | 0 | $0.00 | - | |
| Steven A. J. Salamon - Director | Option exercise | Tranche B warrants to purchase F-4 Preferred Stock | 500 | $1,000.00 | $500K | |
| Steven A. J. Salamon - Director | Other | 8% CONVERTIBLE NOTE | 0 | $0.00 | - | |
| Rosalind Advisors, Inc. - Director | Option exercise | Tranche B warrants to purchase F-4 Preferred Stock | 500 | $1,000.00 | $500K | |
| Rosalind Advisors, Inc. - Director | Other | 8% CONVERTIBLE NOTE | 0 | $0.00 | - | |
| Gerard J. Michel - Officer | Option exercise | Common Stock | 16,666 | $6.00 | $100K | |
| Gerard J. Michel - Officer | Option exercise | Tranche B Warrants to Purchase Common Stock | 16,666 | $0.13 | $2K |
DCTH insider trading FAQ
What is the latest insider trade for DCTH?
DELCATH SYSTEMS, INC. (DCTH) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-14. The full record for DCTH runs to 23 Form 4 filings, the earliest from 2024-10-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DCTH stock?
No insider purchases of DCTH were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling DCTH stock?
No insider sales of DCTH were filed in the last 90 days.
Where can I see DCTH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DCTH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Richard Sylvester view on EDGAR
- - Bridget A. Martell view on EDGAR
- - Elizabeth Czerepak view on EDGAR
- - Steven A. J. Salamon view on EDGAR
- - Gil Aharon view on EDGAR
- - Sandra Pennell view on EDGAR
- - Gerard J. Michel view on EDGAR
- - David L. Hoffman view on EDGAR
- - Kevin Muir view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where DCTH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DCTH with a 7-day demo
- DCTH on your watchlist
- Every DCTH Form 4 filing on record
- Up to 3 months of DCTH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
